DR OBINNA C UBAH (Principal Scientist and Future Leaders Fellow (UKRI)) who leads our autoimmune inflammatory disease team is presenting new data on our lead first in class drug conjugate, ELN 28. His poster entitled, “Development and functional characterisation of ELN28, a Novel soloMER Drug Conjugate (SDC) targeting TNFα and JAK enzymes in Immune Mediated Inflammatory Diseases”, will be presented today, 5th March.
